Karin A H Kaasjager Selected Research

Karin A H Kaasjager Research Topics

4	COVID-19 01/2024 - 01/2021
3	Kidney Diseases (Kidney Disease) 01/2023 - 11/2010
3	Hemorrhage 01/2020 - 03/2002
2	Acute Kidney Injury (Acute Renal Failure) 02/2022 - 01/2021
2	Inappropriate ADH Syndrome (SIADH) 01/2021 - 01/2021
2	Pulmonary Embolism 07/2019 - 01/2017
2	Proteinuria 02/2014 - 09/2012
1	Hypertension (High Blood Pressure) 01/2023
1	Sepsis (Septicemia) 05/2022
1	Chronic Renal Insufficiency 02/2022
1	Infections 01/2022
1	Hyponatremia 01/2021
1	Neoplasms (Cancer) 01/2021
1	Abdominal Pain (Pain, Abdominal) 01/2021
1	Critical Illness (Critically Ill) 01/2021
1	Thrombophilia 01/2021
1	Thrombosis (Thrombus) 01/2020
1	Venous Thromboembolism 01/2017
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2017
1	Chronic Kidney Failure (Chronic Renal Failure) 02/2014
1	Weight Loss (Weight Reduction) 09/2012
1	Anemia 09/2012
1	Diabetic Nephropathies (Diabetic Nephropathy) 11/2010
1	Diabetes Mellitus 11/2010

3	CreatinineIBA 01/2023 - 02/2014
3	SodiumIBA 01/2021 - 09/2012
2	Biomarkers (Surrogate Marker)IBA 05/2022 - 01/2022
2	Vitamin D FDA LinkGeneric 02/2014 - 09/2012
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2014 - 09/2012
2	LDL CholesterolIBA 02/2014 - 09/2012
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2014 - 09/2012
1	Oxygen (Dioxygen)IBA 01/2024
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023
1	LithostathineIBA 05/2022
1	thrombin receptor peptide (42-47)IBA 01/2021
1	IpilimumabIBA 01/2021
1	Crystalloid SolutionsIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Adenosine Diphosphate (ADP)IBA 01/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021
1	DiureticsIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Vasopressins (Vasopressin)IBA 01/2021
1	P-SelectinIBA 01/2021
1	Proton Pump InhibitorsIBA 01/2021
1	Angiotensin Receptor AntagonistsIBA 01/2021
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2020
1	CI 22IBA 07/2019
1	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 01/2017
1	fibrin fragment D (D-dimer)IBA 01/2017
1	Antihypertensive Agents (Antihypertensives)IBA 02/2014
1	Factor VII (Proconvertin)IBA 03/2002

2	Therapeutics 01/2024 - 01/2021
2	Fluid Therapy (Oral Rehydration Therapy) 01/2021 - 01/2021
1	Length of Stay 02/2022
1	Renal Replacement Therapy (Therapies, Renal Replacement) 02/2022
1	Critical Care (Surgical Intensive Care) 11/2021
1	Urinary Catheters 01/2021
1	Catheters 07/2019
1	Contraindications 07/2019
1	Glycemic Control 09/2012
1	Kidney Transplantation 11/2010